Specialty × MAC Jurisdiction Intelligence
HematologyCMS & MAC AlertsCGS Administrators · Jurisdictions J15
Every CMS transmittal, CGS Administrators LCD revision, Federal Register notice, and OIG alert affecting Hematology billing teams in Kentucky, Ohio. Signal-scored and updated daily.
Active alerts
12
Critical / High
2
MAC jurisdiction
J15
Highest-risk CPT
CPT 99213
Recent Hematology alerts under CGS Administrators
2 of the 12 most recent Hematology reimbursement alerts are Critical/High-severity for CGS Administrators (Jurisdictions J15) billing teams. Each links to the source CMS/MAC document with the codes to review and the action to take.
- FDA Approval: MIMRYLO (RUSFERTIDE ACETATE) — Type 1 - New Molecular EntitySep 3, 2026
- FDA Approval: EMPAVELI (PEGCETACOPLAN) — Type 1 - New Molecular EntityAug 26, 2026
- FDA Approval: ZENBEXUS (IBERDOMIDE) — Type 1 - New Molecular EntityAug 19, 2026
- FDA Approval: INJECTAFER (FERRIC CARBOXYMALTOSE INJECTION) — Type 5 - New Formulation or New ManufacturerAug 19, 2026
- FDA Approval: ARGATROBAN (ARGATROBAN) — Type 5 - New Formulation or New ManufacturerAug 6, 2026
- FDA Approval: LYNOZYFIC (LINVOSELTAMAB-GCPT) — Type 1 - New Molecular EntityAug 5, 2026
- FDA Approval: REVLIMID (LENALIDOMIDE) — Type 1 - New Molecular EntityJul 25, 2026
- FDA Approval: VONJO (PACRITINIB) — Type 1 - New Molecular EntityJul 24, 2026
- FDA Approval: JAKAFI (RUXOLITINIB) — Type 1 - New Molecular EntityJul 24, 2026
- FDA Approval: OJJAARA (MOMELOTINIB) — Type 1 - New Molecular EntityJul 24, 2026
- FDA Approval: JAKAFI XR (RUXOLITINIB) — Type 5 - New Formulation or New ManufacturerJul 24, 2026
- FDA Approval: INREBIC (FEDRATINIB HYDROCHLORIDE) — Type 1 - New Molecular EntityJul 24, 2026
Signal intelligence — Hematology × CGS Administrators
Highest-risk CPT code
CPT 99213
Office visit, established patient, low complexity
View full CPT alert profileCGS Administrators jurisdiction
J15
Covers Kentucky, Ohio. Every hematology LCD revision, CMS transmittal, and Federal Register notice affecting these states is signal-scored and surfaced here daily.
View all 12 active alerts for Hematology under CGS Administrators
Full alert text, action recommendations, effective date deadlines, MAC LCD links, and signal score rationale — updated daily.
About CGS Administrators (Jurisdictions J15)
CGS Administrators is the Medicare Administrative Contractor responsible for processing Medicare Part A and Part B claims in Jurisdictions J15, covering Kentucky, Ohio.CGS Administrators issues Local Coverage Determinations (LCDs) that define coverage criteria, ICD-10-CM diagnosis code requirements, and CPT billing guidelines for Hematology procedures within its jurisdiction. CLV Intelligence monitors CGS Administrators's LCD publication feed, provider bulletin archives, and CMS contractor-specific transmittals daily.
Hematology alerts in other MAC jurisdictions
Get weekly Hematology alerts for CGS Administrators — free
No credit card required. Unsubscribe any time.
Frequently asked
- What are the recent CMS updates for Hematology under CGS Administrators MAC?
- According to CLV Intelligence data, updated September 3, 2026, there are currently 12 active CMS and MAC reimbursement policy alerts for Hematology under CGS Administrators (Jurisdictions J15). Of these, 2 are classified Critical or High priority based on signal scoring of source authority, effective-date urgency, and document type. Alerts originate from CGS Administrators Local Coverage Determinations (LCDs), CMS transmittals, Federal Register proposed and final rules, and OIG compliance publications. CLV Intelligence monitors all CGS Administrators publications daily and assigns a signal score (0–100) to surface the changes most likely to affect coding accuracy and reimbursement.
- How many active audit alerts exist for Hematology CPT codes under CGS Administrators?
- According to CLV Intelligence data, 12 active reimbursement and policy alerts currently affect Hematology CPT codes monitored under CGS Administrators (Jurisdictions J15). 2 of these alerts carry a Critical or High signal score, indicating elevated compliance risk or near-term effective dates requiring timely coding review. The highest-risk CPT code currently flagged in the Hematology alert set is CPT 99213 (Office visit, established patient, low complexity), which appears in CGS Administrators LCD and CMS billing guidance revisions. CLV Intelligence cross-references each alert against the HCPCS and CPT code sets to surface procedure-level exposure for Hematology billing teams.
- Which MAC jurisdiction covers Hematology billing for practices in the CGS Administrators region?
- CGS Administrators administers Medicare Part A and Part B claims for practices in Jurisdictions J15. For Hematology providers, CGS Administrators issues Local Coverage Determinations (LCDs) that define coverage criteria, billing requirements, ICD-10-CM diagnosis code ranges, and CPT procedure code guidelines applicable to Medicare claims in its jurisdiction. According to CLV Intelligence data, CGS Administrators monitors 12 open Hematology alerts as of September 3, 2026. Practices in the CGS Administrators jurisdiction should monitor LCD revisions at CGS Administrators's provider portal and through aggregated daily alerting services such as CLV Intelligence.
- Is CPT 99213 currently under CMS or MAC review for Hematology?
- According to CLV Intelligence data, CPT 99213 (Office visit, established patient, low complexity) is currently flagged as a high-signal procedure code within the Hematology alert set monitored under CGS Administrators (Jurisdictions J15). CMS and MAC contractors regularly review high-volume procedure codes for coverage criteria changes, NCCI edit revisions, medical necessity documentation requirements, and fee schedule adjustments. CLV Intelligence assigns CPT 99213 an elevated signal score based on the volume and recency of policy documents referencing this code. Hematology coding teams should review the latest CGS Administrators LCD and CMS transmittals affecting CPT 99213 before claim submission to avoid denials or post-payment audits.